Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%) Cadila Healthcare informs about appointment of Director
Date: 16-05-2014Cadila Healthcare has informed that the Board of Directors of the company at its meeting held on May 16, 2014, has appointed Dharmishta N. Rawal, an eminent lawyer as an Additional Director.
The above information is a part of company’s filings submitted to BSE.